Showing results 1 to 6 of 6
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza Journal:Journal of Antimicrobial Chemotherapy | 2008 | |||
DAS181 inhibits H5N1 influenza virus infection of human lung tissues Journal:Antimicrobial Agents and Chemotherapy | 2009 | 165 | ||
DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis. Journal:The Journal of antimicrobial chemotherapy | 2010 | 111 | ||
| 2009 | 200 | |||
Pandemic H1N1 2009 and Drug Resistant Influenza Viruses are Potently Inhibited by DAS181, a Sialidase Fusion Protein Proceeding/Conference:Interscience Conference on Antimicrobial Agents and Chemotherapy, ICAAC 2009 | 2009 | 172 | ||
The use of sialidase treatment in influenza virus infection Proceeding/Conference:International Symposium on Respiratory Viral Infections | 2009 | 90 |